Your browser doesn't support javascript.
loading
Bringing safe and effective therapies to premenopausal women with breast cancer: efforts to broaden eligibility criteria.
Gao, J J; Krol, D; Narayan, P; Cardoso, F; Regan, M M; Goetz, M P; Hurvitz, S A; Mauro, L; Hodgdon, C; Miller, C P; Booth, B; Bloomquist, E; Ison, G; Osgood, C; Bhatnagar, V; Fashoyin-Aje, L; Pazdur, R; Amiri-Kordestani, L; Beaver, J A.
Afiliación
  • Gao JJ; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, USA. Electronic address: Jennifer.gao@fda.hhs.gov.
  • Krol D; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
  • Narayan P; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
  • Cardoso F; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation and ABC Global Alliance, Lisbon, Portugal.
  • Regan MM; Division of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
  • Goetz MP; Department of Oncology and Pharmacology, Mayo Clinic, Rochester, USA.
  • Hurvitz SA; David Geffen School of Medicine, University of California Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, USA.
  • Mauro L; Inova Schar Cancer Institute, Fairfax, USA.
  • Hodgdon C; Patient Advocate.
  • Miller CP; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
  • Booth B; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
  • Bloomquist E; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
  • Ison G; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
  • Osgood C; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
  • Bhatnagar V; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, USA.
  • Fashoyin-Aje L; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, USA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
  • Pazdur R; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, USA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
  • Amiri-Kordestani L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
  • Beaver JA; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, USA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
Ann Oncol ; 32(8): 950-953, 2021 08.
Article en En | MEDLINE | ID: mdl-33991601
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido